1. Home
  2. VIPS vs PCVX Comparison

VIPS vs PCVX Comparison

Compare VIPS & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vipshop Holdings Limited

VIPS

Vipshop Holdings Limited

HOLD

Current Price

$13.28

Market Cap

7.7B

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$50.17

Market Cap

7.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIPS
PCVX
Founded
2008
2013
Country
China
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7B
7.0B
IPO Year
2012
2020

Fundamental Metrics

Financial Performance
Metric
VIPS
PCVX
Price
$13.28
$50.17
Analyst Decision
Buy
Strong Buy
Analyst Count
4
4
Target Price
$19.58
$88.25
AVG Volume (30 Days)
2.7M
1.4M
Earning Date
05-19-2026
05-07-2026
Dividend Yield
4.38%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.79
N/A
Revenue Next Year
$2.05
N/A
P/E Ratio
$9.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.44
$29.10
52 Week High
$21.08
$65.00

Technical Indicators

Market Signals
Indicator
VIPS
PCVX
Relative Strength Index (RSI) 35.04 51.24
Support Level N/A $48.49
Resistance Level $15.11 $52.00
Average True Range (ATR) 0.37 1.96
MACD -0.03 0.58
Stochastic Oscillator 0.88 76.02

Price Performance

Historical Comparison
VIPS
PCVX

About VIPS Vipshop Holdings Limited

Vipshop is a leading Chinese online discount retailer offering branded products at attractive discounts of 10%-90% off their original price through daily flash sales. It operates warehousing, retailing, product procurement, software development, and information technology support in-house while outsourcing to third-party logistics providers for distribution and shipments. Branded products on Vipshop's platform are sourced mostly through a consignment model with global brand partners. As of March 31, 2025, Eric Ya Shen, chair and CEO, had 64.5% voting rights. Leading Chinese social media firm and strategic shareholder Tencent also holds a 12.5% interest.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

Share on Social Networks: